Back to mobile site

UPDATE: Piper Sandler Downgrades Aligos Therapeutics Inc. (ALGS) to Neutral on ALG-020572 Discontinuation

March 23, 2022 4:23 AM EDT Send to a Friend
(Updated - March 23, 2022 8:55 AM EDT)

Piper Sandler analyst Tyler Van Buren downgraded Aligos Therapeutics Inc. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login